At 3 a.m. EDT on the Fourth of July, among a cadre of high-energy particle physicists around the country, euphoria made sleep impossible. Champagne flowed freely, as physicists celebrated the news that the decades-long quest for the Higgs boson was over.
Two research teams working at the Large Hadron Collider had nailed down the elusive particle, which theoretical physicists, including Peter Higgs, a Scotsman, had postulated years ago was the creator of mass. For science, the victory could not have been sweeter. But for American science, the victory was bittersweet.
The Large Hadron Collider, you see, is not on American soil. It straddles the Swiss-French border outside Geneva.
And ITER, the world's largest science project ever, which focuses on fusion energy, is not on American soil either. It is under construction in Cadarache, about 35 miles northeast of Marseille, France.
Finally, except for an eleventh-hour intervention by Sen. Barbara Mikulski (D-Md.) last year, Congress would have scuttled America's astronomical centerpiece, the James Webb Space Telescope, leaving the European Space Agency to pick up NASA's detritus.
It seems everywhere you look these days our nation is shying away from anything big in science. And that does not bode well for the future. After all, the World Wide Web sprang from high- energy physics, the epitome of big science. And many medical diagnostic and cancer treatment tools - CT scans, PET scans and proton therapy, among them - trace their origins largely to big science.
The will to do big things is weak in both political parties but especially so among the more recently minted members of the House majority. The major shift in support of science spending among Republicans, who used to epitomize the commitment of patient capital for long-term research, was the subject of my last column.
And it led to howls from a few GOP Congressional offices known for ardent support of science. They were right to object to being painted with one stroke of a broad brush. But voting records on authorizations or appropriations are not easy to explain away.
In the last month, I've explored the problem with several Congressional offices and concluded that misconceptions and myths abound. For the cadre of recent arrivals - with a dedication to setting spending priorities that their more experienced colleagues sometimes lack - the full story of American science remains either unread or unheard.
A few key points can start the process.
If you are a believer in American exceptionalism, you must become a science adherent: Science has been the prime driver of the American economy for more than half a century. Science won World War II, and science has protected our men and women in uniform who have served in combat ever since.
If you are a believer in market principles and entrepreneurship, you must become an admirer of America's scientific enterprise: Research, as we perform it in the United States, is a cutthroat business. It represents a marketplace of the best ideas, and with few exceptions, only the soundest concepts can survive the scrutiny of peer review for very long.
Rep. Bill Cassidy has his blood drawn by Alesha Barbour during a free hepatitis screening in the Rayburn House Office Building hosted by the Congressional Viral Hepatitis Caucus to recognize "National Viral Hepatitis Testing Day."
Roll Call has launched a new feature, Hill Navigator, to advise congressional staffers and would-be staffers on how to manage workplace issues on Capitol Hill. Please send us your questions anything from office etiquette, to handling awkward moments, to what happens when the work life gets too personal. Submissions will be treated anonymously.